Auxly Cannabis Group. (OTCQB: CBWTF), established in 1987 in Vancouver (Canada), engages in the cannabis streaming industry where it also provides fun...
Vipshop Holdings, Growing the Top Line with Collaborations, Analysts Review
Vipshop Holdings Limited (NASDAQ: VIPS) operates as an online discount retailer for various brands in the People’s Republic of China. It operate...
Medigus Restructuring Could Prove to be a Smart Move
Medigus Ltd. (NASDAQ: MDGS), a medical device company, develops, manufactures, and markets surgical endostaplers and direct vision systems for minimal...
Aegean Marine, Acquisition and Financing Agreements to Facilitate Growth, Analysts Review
Aegean Marine Petroleum Network Inc. (NYSE: ANW), is an international marine fuel logistics company that markets and physically supplies refined marin...
Veon Ltd. Analysts Review and Target, Company’s 2018 Guidance and Recent Highlights
VEON Ltd. (NASDAQ: VEON) is a NASDAQ and Euronext Amsterdam-listed global provider of connectivity and internet services, with an ambition to lead the...
Leading Brands Revamps its Business and Sees a Future in the Media and Gaming Sectors
Leading Brands, Inc. (NASDAQ: LBIX) was founded on February 4, 1986, and is headquartered in Vancouver, Canada. On May 30th, the company announced res...
Taitron Components Shares Jumped Last Week, Revamping its Product Focus and Distribution
Taitron Components, Inc. (NASDAQ: TAIT) manufactures and distributes electronic components. It distributes brand name electronic components and suppli...
Valeritas Holdings, New Study Results Pump Up V-Go Insulin Delivery Device
Valeritas Holdings, Inc. (NASDAQ: VLRX) is a commercial-stage medical technology company, focuses on the development and commercialization of technolo...
Catabasis Pharmaceuticals, Edasalonexent for the Treatment of Duchenne Muscular Dystrophy Showing Early Clinical Success
Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB), is a clinical-stage biopharmaceutical company. The company’ SMART (Safely Metabolized and Rationally T...
EyePoint Pharmaceuticals, Acquisition, NDA and PDUFA Date, Pipeline Update
EyePoint Pharmaceuticals (NASDAQ: EYPT), is a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic pr...